Skip to main content
  1. Courses
  2. ISMPP U - Open to all 90-mi...
  3. ISMPP U - Open to all 90-mi...

ISMPP U - Open to all 90-minute ISMPP U! The AI Evolution: Medical Communications in the Digital Age (June 12, 2024)

Thank you

To view the free recording and slides you will need to login or sign up to create an account.

Description

In honor of Medcomms Day, ISMPP is proud to offer this 90-minute webinar open to both members and nonmembers. The integration of generative AI into the creation of scientific communication materials not only promises to revolutionize engagement by providing more accessible and timely communication of complex data, but also signifies a paradigm shift in medical communications. Embracing AI technologies has the potential to enhance the quality and reach of medical communications materials across the pharmaceutical industry. Despite the exciting potential of AI, challenges in the development and implementation of such tools are evident. These challenges include ensuring compliance with regulatory standards, maintaining accuracy in data interpretation, and effectively integrating AI technologies with existing workflows within the pharmaceutical industry.

Drawing from experience in developing a generative AI tool for PLS, this webinar will explore the practicalities of creating and implementing such technologies. Participants will learn the nuances of balancing innovation with regulation, the importance of interdisciplinary collaboration, and the critical hurdles that must be overcome to ensure tool reliability and effectiveness. The session aims to provide cover experience sharing, strategies, and best practices, as well as the limitations and ethical considerations that come with employing generative AI in medical communications.

Learning Objectives: At the end of this session attendees will:

  • To discuss the integration of AI tools into the publication process from an industry publisher's perspective.
  • Gain an understanding of AI and explore the advantages and limitations of using generative AI for PLS development.
  • To share insights and learnings from the development of an AI tool for PLS creation.
  • To understand the ethical considerations surrounding generative AI in patient communications.
  • To evaluate the implications of AI technology on the future of scientific communication within the pharmaceutical industry.

Approved for 1.5 CMPP credit

Contributors

  • Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer, Inizio Medical

    • 25 years in life experiences, with roles in small pharma, private and public-side organizations, not-for-profit professional society, patient advocacy, agency and consultancy organizations.
    • Therapeutic area depth in oncology/hematology, neuropsychiatry and rare disorders.
    • Founded the Inizio Medical Analytics and Innovation team, with an emphasis on advanced analytics, digital consulting and software as a service digital transformation partnership.
    • Practice lead for augmented intelligence across Inizio Medical; lead on the Generative AI workstream for MAPS, lead AI author for HCA’s AI Roadmap (published in CMRO).
    • Executive Lead for Inizio’s Mental Health and Wellbeing Business Employee Resource Group.

  • Yahya Anvar, Chief of AI Science and Insights, OKRA Technologies

    • Dr Yahya Anvar currently serves as Head of OKRA.ai and Chief AI Science & Insights Officer at Envision Pharma Group.
    • During his tenure at OKRA.ai, he has overseen the development and productization of AI solutions across the drug life-cycle continuum to improve patient outcomes. His team has developed and implemented groundbreaking AI solutions with a focus on explainability, actionability, and keeping the human in the loop.
    • Prior to this, he was a senior scientist, serving as principal investigator of preclinical personalised medicine at Leiden University Medical Centre (LUMC). He has over 15 years of experience in the healthcare sector and is the author of over 30 peer-reviewed scientific articles.
    • He holds a PhD in Medicine, with a focus on bioinformatics and computational biology, from Leiden University, and MSc in Bioinformatics and Artificial Intelligence from Brunel University.

  • Hélène Dassule, Head of Strategy and Excellence GHEOR, GMC, Training/Field Capabilities, Alexion Pharmaceuticals

    • Hélène Dassule has over 20 years of experience in Scientific Communications. After completing her PhD in molecular and cellular biology at Harvard University, she joined the Scientific Communications team at Bayer Pharmaceuticals to assist with the development and implementation of communications strategies.
    • She continued her medical writing career as a Senior Editor at Parexel Medical Communications, Inc, and then worked for over 15 years as an independent publications consultant in a range of therapeutic areas.
    • In 2022, she joined Alexion AstraZeneca Rare Disease as a Director of Scientific Communications where she successfully worked on publications and publications plans across a number of therapeutic areas.
    • Since taking on operational excellence as the head of Strategy and Excellence for Global Medical Communications and Health Economics and Outcomes Research, she has been ensuring the implementation best publication practices, optimizing departmental efficiency, and fostering innovation.

  • Simon Foulcer, Director, BPM Evidence Publications, AstraZeneca

    • Simon is a Global Publication Lead at AstraZeneca with over 10 years of experience in the pharmaceutical industry. His primary responsibility is overseeing the strategic publications plan for products within AstraZeneca's CVRM portfolio.
    • In his current role, Simon develops and implements publication strategies that effectively communicate the scientific advancements and therapeutic benefits of our products.
    • He has a diverse background, spending time in both medical communications consulting and a Contract Research Organization (CRO), and so possesses a comprehensive understanding of the pharmaceutical landscape and the complexities of scientific publications.
    • Simon is passionate about driving innovation, for example by incorporating AI into publication workflows, with the goal of delivering meaningful information that empowers patients and healthcare professionals and ensures that publications are accessible, accurate, and impactful.
    • He also strongly advocates for diversity in clinical trials, recognizing the vital role it plays in developing treatments that are effective for all patients. By actively promoting diversity, we can ensure that our publications reflect the real-world patient population, leading to more inclusive and personalized healthcare solutions.

June 12, 2024
Wed 11:00 AM EDT

Duration 1H 30M

This live web event has ended.

ISMPP U Support
ismpp@ismpp.org